Mydecine Announces First Quarter 2022 Financial Results and
DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...
United States Morgan Kervitsky Josh Bartch Joshua Bartch Mydecine Innovations Group Inc Health Canada Special Access Program
Source: globenewswire.com